Lee Howard 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
Lee Howard
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-01$16.69/sh+16,679$278,373→ 159,618 total - Sale
Common Stock
[F1]2023-06-01$45.02/sh−16,679$750,960→ 142,939 total - Exercise/Conversion
Stock Option (right to buy)
[F2]2023-06-01−16,679→ 0 totalExercise: $16.69Exp: 2026-06-07→ Common Stock (16,679 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.80 to $45.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Shares subject to the option are fully vested and immediately exercisable.
Signature
/s/ Eva Wen, by power of attorney|2023-06-05